SCHEMBL891882

SCHEMBL891882

FC(OC(F)(F)F)C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29989099 0.88
SCHEMBL21816709 0.73
SCHEMBL9551128 0.73
SCHEMBL20349480 0.73 MEN1 (0.33) MEN1KMT2A
SCHEMBL20349522 0.73 MEN1 (0.33) MEN1KMT2A
SCHEMBL25238001 0.73
SCHEMBL5069059 0.73
SCHEMBL1148354 0.73
SCHEMBL13281699 0.73
SCHEMBL15513894 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3863089-B1 LITHIUM SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2026-04-01 EP claimed
EP-3813156-B1 LITHIUM-SULFUR SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2026-02-18 EP claimed
US-12548763-B2 Lithium-sulfur secondary battery LG ENERGY SOLUTION, LTD. (KR) 2026-02-10 US claimed
EP-3951931-B1 LITHIUM SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2026-01-28 EP claimed
US-12469880-B2 Electrolyte additives for lithium-sulfur rechargeable battery THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-11 US claimed
US-20250323323-A1 MIXED ELECTROLYTE FOR RECHARGEABLE BATTERY UNIV CALIFORNIA (US) 2025-10-16 US claimed
US-12407025-B2 Lithium secondary battery LG ENERGY SOLUTION, LTD. (KR) 2025-09-02 US claimed
EP-3940822-B1 LITHIUM-SULFUR SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2025-08-27 EP claimed
EP-3751640-B1 LITHIUM-SULFUR SECONDARY BATTERY LG ENERGY SOLUTION LTD (KR) 2025-07-16 EP claimed
EP-4120422-B1 ELECTROLYTE FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2025-06-04 EP claimed
WO-2002003958-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE ASTRAZENECA AB (SE) 2002-01-17 WO claimed
JP-2001504884-A 2001-04-10 JP claimed
EP-0954555-A1 REFRIGERANT COMPOSITION RHODIA LIMITED (GB) 1999-11-10 EP claimed
JP-2923362-B2 1999-07-26 JP claimed
WO-1998023702-A1 REFRIGERANT COMPOSITION RHODIA LIMITED (GB) 1998-06-04 WO claimed
EP-0699222-A1 REFRIGERANT COMPOSITIONS INCLUDING AN ACYCLIC FLUOROETHER E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-03-06 EP claimed
EP-0664823-A1 REFRIGERANT COMPOSITIONS INCLUDING BIS(DIFLUOROMETHYL) ETHER E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-08-02 EP claimed
WO-1994026837-A1 REFRIGERANT COMPOSITIONS INCLUDING AN ACYCLIC FLUOROETHER E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-11-24 WO claimed
CN-1087932-A The refrigerant compositions that comprises two (difluoromethyl) ether DU PONT (US) 1994-06-15 CN claimed
WO-1994009083-A1 REFRIGERANT COMPOSITIONS INCLUDING BIS(DIFLUOROMETHYL) ETHER E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-04-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12548763-B2 Lithium-sulfur secondary battery SCO2, PDHB, CACNA2D1 MEN1 1774/4885KMT2A 1520/4885
US-12469880-B2 Electrolyte additives for lithium-sulfur rechargeable battery SLC26A3, SLC39A14, TRPM6 MEN1 1334/4885KMT2A 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.